Effect of aflibercept in insufficient responders to prior anti-VEGF therapy in neovascular AMD
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of aflibercept in insufficient responders to prior anti-VEGF therapy in neovascular AMD
Authors
Keywords
Age-related macular degeneration, Aflibercept, Ranibizumab, Bevacizumab, Tolerance, Tachyphylaxis
Journal
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
Volume 252, Issue 11, Pages 1705-1709
Publisher
Springer Nature
Online
2014-03-10
DOI
10.1007/s00417-014-2589-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Conversion to Aflibercept For Chronic Refractory Or Recurrent Neovascular Age-Related Macular Degeneration
- (2013) Yoshihiro Yonekawa et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Short-Term Outcomes of Aflibercept for Neovascular Age-Related Macular Degeneration in Eyes Previously Treated With Other Vascular Endothelial Growth Factor Inhibitors
- (2013) Vincent Y. Ho et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Aflibercept Therapy for Exudative Age-related Macular Degeneration Resistant to Bevacizumab and Ranibizumab
- (2013) Benjamin Bakall et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Aflibercept for exudative AMD with persistent fluid on ranibizumab and/or bevacizumab
- (2013) Hyung Cho et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Rapid response of retinal pigment epithelial detachments to intravitreal aflibercept in neovascular age-related macular degeneration refractory to bevacizumab and ranibizumab
- (2013) K H Patel et al. EYE
- Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial
- (2013) Usha Chakravarthy et al. LANCET
- Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZON
- (2013) Soraya Rofagha et al. OPHTHALMOLOGY
- VISUAL AND ANATOMICAL OUTCOMES OF INTRAVITREAL AFLIBERCEPT IN EYES WITH PERSISTENT SUBFOVEAL FLUID DESPITE PREVIOUS TREATMENTS WITH RANIBIZUMAB IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
- (2013) Nishant Kumar et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
- (2012) Daniel F. Martin et al. OPHTHALMOLOGY
- Bevacizumab and ranibizumab tachyphylaxis in the treatment of choroidal neovascularisation
- (2011) Julie L Gasperini et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Tachyphylaxis during treatment of exudative age-related macular degeneration with ranibizumab
- (2011) Maria Salling Eghøj et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Loss of reactivity in intravitreal anti-VEGF therapy: tachyphylaxis or tolerance?
- (2011) Susanne Binder BRITISH JOURNAL OF OPHTHALMOLOGY
- INTRAOCULAR PHARMACOKINETICS AFTER A SINGLE INTRAVITREAL INJECTION OF 1.5 mg VERSUS 3.0 mg OF BEVACIZUMAB IN HUMANS
- (2011) Carsten H Meyer et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- NOVEL METHOD FOR ANALYZING SNELLEN VISUAL ACUITY MEASUREMENTS
- (2010) Ninel Z Gregori et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Investigation of the role of neutralizing antibodies against bevacizumab as mediators of tachyphylaxis
- (2009) Farzin Forooghian et al. ACTA OPHTHALMOLOGICA
- Is There Tachyphylaxis to Intravitreal Anti-Vascular Endothelial Growth Factor Pharmacotherapy in Age-Related Macular Degeneration?
- (2008) Shlomit Schaal et al. OPHTHALMOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search